Skip to main content

Incidence of Lung Cancer Higher in Women Versus Men Aged 35 to 54 Years

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Oct. 12, 2023 -- The incidence of lung cancer is higher in women than men aged 35 to 54 years, according to a research letter published online Oct. 12 in JAMA Oncology.

Ahmedin Jemal, D.V.M., Ph.D., from the American Cancer Society in Atlanta, and colleagues monitored shifts in lung cancer incidence by age and sex in a cross-sectional study on lung and bronchus cancer diagnosed from 2000 to 2019. Cases were stratified by sex, age in five-year increments, and year of diagnosis.

The researchers observed greater declines in incidence rates between 2000-2004 and 2015-2019 in men than women, resulting in higher incidence among women aged 35 to 54 years. As a result, there was an increase seen in the female-to-male incidence rate ratio from 0.73 during 2000 to 2004 to 1.05 during 2015 to 2019. Incidence rates continued to be lower in women among individuals aged 55 years or older, although the differences became progressively smaller. For example, the female-to-male incidence rate ratio increased from 0.62 to 0.81 during 2000-2004 and 2015-2019, respectively, among persons aged 70 to 74 years.

"We found that the higher lung cancer incidence in women than in men has not only continued in individuals younger than 50 years but also now extends to middle-aged adults as younger women with a high risk of the disease enter older age," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted October 2023

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.